Top Stories
-
A combination of genetic and lab testing could identify 1 million Americans who are at risk of early death from heart disease because they carry a gene that causes high cholesterol.
Topic
-
The Columbia Hypertension Center has been certified by the American Heart Association, recognition that Columbia is a leader in the care of patients with high blood pressure.
-
Internationally renowned “surgeon’s surgeon” is known for his skill in highly complex cases.
Topic
-
Heart disease is the No. 1 one cause of death in American women, yet most are unaware of the risks and most cardiovascular studies are about men.
Topic
Latest News
- April 12, 2018
Columbia bioengineers used an electromechanical "workout" program to turn human stem cells into adult-like heart tissue in just four weeks.
Topic
- February 23, 2018
Among children with congenital heart disease, those from low-income neighborhoods have higher mortality than kids from high-income areas, even when treated at the same hospitals.
Topic
- February 14, 2018
Andrew Moran, MD, internist and hypertension expert, addresses questions about the new blood pressure treatment guidelines.
Topic
- November 30, 2017
The first human heart transplant took place 50 years ago in South Africa, but Columbia was among a handful of places that helped the field mature.
Topic
- October 13, 2017
The Vivian and Seymour Milstein Family Infant Cardiac Unit is a state-of-the-art, 17-bed unit staffed by a multidisciplinary team of specialists in neonatal cardiac intensive care.
Topic
- September 21, 2017
Macrophages can eat up to 70 dead cells a day, preventing atherosclerosis. A new CUIMC study finds that mitochondria play a critical role in the process.
Topic
- September 11, 2017
Sitting around for one to two hours at a time without moving increases the risk of death, finds a new study.
Topic
-
Source:
The New York TimesAugust 28, 2017 - August 23, 2017
Higher up-front costs for intensive blood pressure control are outweighed by long-term cardiac benefits, shows study.
Topic
- August 15, 2017
A new clinical trial will determine if the drug apixaban can prevent recurrent strokes in people with atrial cardiopathy.
